Skip to main content
TipRanks
Go Ultimate75% OFF

Hannover Rueck SE (HVRRY) AI Stock Analysis

29 Followers
HVRRY

Hannover Rueck SE

(Other OTC:HVRRY)

Select Model
Rating:77Outperform
Price Target:$62.00â–²(13.26% Upside)
Action:reiterated
Date:11/12/26

Hannover Re's overall score of 77 reflects a financially robust company with a fortress-like balance sheet and strong underwriting profitability, trading at an exceptionally low valuation. The primary driver is the combination of high financial strength and a deeply discounted P/E ratio with a high dividend yield. The constructive earnings call, confirming the company is on track to meet or beat its targets, adds further confidence. The main factors tempering the score are the volatility in free cash flow conversion and technical indicators suggesting the recent bullish momentum may be due for a pause.

Positive Factors
Strong P&C Underwriting ProfitabilityA combined ratio well below target indicates that premium pricing and risk selection are currently generating substantial underwriting profit. This supports durable earnings quality, strengthens reserve resilience, and provides a solid operating base even if catastrophe activity or market conditions normalize.
Negative Factors
P&C Competition and Rate PressureFalling rates and lower new business CSM indicate that competition is pressuring the economics of new P&C business. If capacity remains abundant, Hannover Re may face lower pricing power, slower growth in profitable contracts, and pressure on future underwriting margins.

Hannover Rueck SE (HVRRY) vs. SPDR S&P 500 ETF (SPY)

-10%-5%0%5%10%15%20%HVRRY+14.23%SPY+13.89%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$39.42B
Dividend Yield
4.51%
Average Volume (3M)
11.91K
Price to Earnings (P/E)
3.9
Beta (1Y)
0.18
Revenue Growth
7.33%
EPS Growth
17.38%
Country
US
Employees
4,078
Sector
Financial
Sector Strength
68
Industry
Insurance - Reinsurance

Hannover Rueck SE Business Overview & Revenue Model

Company Description

Hannover Rück SE, through its network of global subsidiaries, functions as a prominent international supplier of extensive reinsurance solutions and related services. Its business operations are primarily divided into two main areas: Property & Casua...

How the Company Makes Money

Hannover Re primarily makes money through (1) underwriting reinsurance risk and (2) investing the float (premiums received and reserves held before claims are paid). 1) Reinsurance underwriting income (core operating revenue) - Premiums from reinsura...

Hannover Rueck SE Earnings Call Summary

Earnings Call Date:Nov 09, 2026(Q3-2026)|% Change Since:0.57%|Next Earnings Date:Mar 11, 2027
Earnings Call SentimentPositive

The call was strongly constructive. Hannover Re reported robust profitability, a low P&C combined ratio, strong investment returns, excellent capitalization, positive Life & Health performance, and progress toward its full-year targets. The main challenges were intensified P&C competition, a EUR 300 million year-on-year decline in P&C new business CSM, higher capital requirements, assumption-related Life & Health impacts, currency losses, and higher unrealized fixed-income losses. Overall, the positive operating and financial trends significantly outweighed the stated challenges.

Positive Updates

Strong Group Net Income and Full-Year Progress
Group net income reached EUR 2.1 billion for the first 9 months of 2026, and management said the company is well on track to deliver its full-year group net income target.

Negative Updates

Increased Competition in P&C Reinsurance
The overall loss environment in P&C reinsurance was benign, but increased reinsurance capacity intensified competition. Management noted that reinsurance rates remain risk adequate on a broad basis.

Company Guidance

Hannover Re maintained its guidance for the current year with a clear ambition to meet expectations, said the lower end of its 2026 P&C growth target remains within reach and the lower end of its target range should still be achievable, and expects the Life & Health reinsurance service result to meet its full target of around EUR 925 million; P&C’s combined ratio target is below 87%, the return on investment target is 3.5%, the normal expected runoff result is EUR 150 million to EUR 200 million, and the risk adjustment release is not generally expected to exceed the indicated range of 6% to 8%. Details of the 2027 earnings, combined ratio, discounting factor, revenue and midterm outlook will be provided at the Investors Day on the 25th of November, with revenue guidance including both traditional and structured reinsurance P&C business.

Hannover Rueck SE Financial Statement Overview

Summary

Financial performance is strong, driven by a robust balance sheet (Score: 85) with low leverage and high ROE, and a solid income statement (Score: 78) showing excellent revenue growth and underwriting margins. However, the cash flow score (65) is a drag due to volatile free cash flow conversion, which tempers the overall financial picture.

Income Statement

78Positive

Balance Sheet

85Very Positive

Cash Flow

65Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue28.59B24.02B2.66B1.13B1.39B26.15B
Gross Profit21.93B22.87B2.53B1.04B1.31B20.39B
EBITDA9.96B3.41B3.37B2.10B1.44B1.90B
Net Income2.72B2.64B2.33B1.82B780.80M1.23B
Balance Sheet
Total Assets75.30B71.30B72.13B65.67B62.96B82.90B
Cash, Cash Equivalents and Short-Term Investments60.89B1.05B57.39B52.63B46.65B47.59B
Total Debt04.14B4.67B4.88B5.51B4.37B
Total Liabilities60.57B57.37B59.44B54.65B53.00B70.15B
Stockholders Equity13.67B12.92B11.79B10.13B9.06B11.89B
Cash Flow
Free Cash Flow3.04B5.69B5.68B5.79B5.16B4.60B
Operating Cash Flow6.78B5.46B5.68B5.79B5.16B4.94B
Investing Cash Flow-5.18B-3.89B-4.41B-4.51B-5.38B-5.26B
Financing Cash Flow-1.73B-1.65B-1.10B-1.50B133.25M277.51M

Hannover Rueck SE Technical Analysis

Technical Analysis SentimentPositive
Last Price54.74

Price Trends

50DMA50.60Positive
100DMA49.28Positive
200DMA48.43Positive

Market Momentum

MACD1.37Negative
RSI59.05Neutral
STOCH32.28Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HVRRY, the sentiment is Positive. The current price of 54.74 is above the 20-day moving average (MA) of 53.27, above the 50-day MA of 50.60, and above the 200-day MA of 48.43, indicating a bullish trend. The MACD of 1.37 indicates Negative momentum. The RSI at 59.05 is Neutral, neither overbought nor oversold. The STOCH value of 32.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HVRRY.

Hannover Rueck SE Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

HVRRY against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HGHG85Outperform$3.79B7.2823.92%―18.05%22.42%
SPNTSPNT79Outperform$3.11B6.5021.64%―18.14%163.19%
RGARGA78Outperform$17.78B10.5113.15%1.38%22.58%99.93%
HVRRYHVRRY77Outperform$39.30B3.9067.35%4.51%7.33%17.38%
RNRRNR76Outperform$14.30B10.1213.52%0.46%-21.18%-3.27%
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
EGEG65Neutral$15.70B9.0312.52%1.89%-8.72%250.85%

* Financial Sector Average

Performance Comparison

0%20%40%HVRRYEGRGARNRSPNTHGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HVRRY and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HVRRYHannover Rueck SE (ADR)54.746.4213.29%
EGEverest Group, Ltd.422.33103.8432.60%
RGAReinsurance Group Of America273.7487.3846.89%
RNRRenaissancere354.6692.5335.30%
SPNTSiriuspoint Ltd26.816.4831.87%
HGHamilton Insurance Group, Ltd. Class B38.7414.3758.95%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 11, 2026